Cancer Genetics Inc.


Cancer Genetics Inc. is an emerging leader in DNA-based cancer diagnostic testing. The company's proprietary tests target cancers that are difficult to diagnose and predict treatment outcomes that include hematologic, urogenital and HPV-associated cancers. Servicing prestigious medical institutions throughout the world, Cancer Genetics also offers a comprehensive range of non-proprietary, oncology-focused tests and laboratory services that provide critical genomic information to help devise patient management.